Abasaglar ® (insulin glargin)

För fullständig produktresumé för Abasaglar® se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Abasaglar® (insulin glargin): Dosering och administrering

Korrekt administrering och dosering av Abasaglar kräver att specifika instruktioner följs.

Administration Instructions

Insulin label must always be checked before each injection to avoid medication errors between Abasaglar and other insulins.1

The patient should be advised to read the instructions for use included in the package leaflet carefully before using Abasaglar.1  

Inspect Abasaglar before use. It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency. 1

Inject between 1 and 80 units of Abasaglar per injection.2

Abasaglar is administered subcutaneously into the abdominal area, deltoid or thigh.1

Injection sites should always be rotated within the same region in order to reduce the risk of lipodystrophy and cutaneous amyloidosis.1

Abasaglar must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.2

Abasaglar should not be administered intravenously.2

 

Dosing Instructions

In patients with T1DM, use Abasaglar concomitantly with mealtime insulin.3

In patients with T2DM, Abasaglar can also be given together with OAMs.1

Abasaglar should be administered once daily at any time but at the same time each day.1

The Abasaglar dose regimen (dose and timing) should be individually adjusted.1

 

Perform dosage adjustments of Abasaglar under medical supervision and with appropriate glucose monitoring.

Dosage adjustments may be needed with

  • changes in physical activity

  • changes in meal patterns

  • episodes of acute illness, or

  • changes in renal or hepatic function.1

References

1. Abasaglar [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Abasaglar [instructions for use]. Eli Lilly Nederland B.V., The Netherlands .

3. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Glossary

Abasaglar = Abasaglar® (insulin glargine) 100 units/mL

OAM = oral antihyperglycemic medication

T1DM = type 1 diabetes mellitus

T2DM = type 2 diabetes mellitus

Datum fӧr senaste ӧversyn 2019 M07 22


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Skriv din fråga till oss